DexCom stock price target maintained at $100 by TD Cowen on G7 issues resolution
PositiveFinancial Markets

TD Cowen has maintained its stock price target for DexCom at $100, reflecting confidence in the company's performance amid ongoing G7 issues. This stability is significant as it indicates that analysts believe DexCom will navigate current challenges effectively, which could reassure investors and potentially boost stock performance.
— Curated by the World Pulse Now AI Editorial System